Immunic (IMUX) Prepaid Assets (2013 - 2026)
Immunic (IMUX) posted Prepaid Assets of $1.1 million for Q1 2026, down 11.75% sequentially from $1.2 million in Q4 2025, and down 15.55% YoY from $1.3 million in Q1 2025.
Analysis
Immunic (IMUX) Prepaid Assets (2013 - 2026) Analysis & Trends
Immunic has reported Prepaid Assets for 14 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Prepaid Assets fell 15.55% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 15.55% YoY) and the FY2025 annual result came in at $1.2 million, down 67.25% from the prior year.
- Prepaid Assets fell to $1.1 million in Q1 2026 per IMUX's latest filing, from $1.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $16.7 million in Q2 2022 and troughed at $818000.0 in Q3 2025.
- A 5-year average of $4.4 million and a median of $3.7 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 1015.17% in 2022, then sank 83.69% in 2025.
- Over 5 years, Prepaid Assets stood at $9.5 million in 2022, then plunged by 38.25% to $5.9 million in 2023, then slumped by 37.47% to $3.7 million in 2024, then tumbled by 67.25% to $1.2 million in 2025, then fell by 11.75% to $1.1 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.1 million, $1.2 million, and $818000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Immunic | 546.30 Mn | 546.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 7.39 Mn |
| Sep 30, 2025 | 4.14 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.67 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 5.86 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 9.26 Mn |
| Mar 31, 2023 | 9.47 Mn |
| Dec 31, 2022 | 9.49 Mn |
| Sep 30, 2022 | 13.88 Mn |
| Jun 30, 2022 | 16.68 Mn |
| Mar 31, 2022 | 20.17 Mn |
| Dec 31, 2021 | 18.13 Mn |
| Sep 30, 2021 | 12.05 Mn |